Stacy Lauderdale, Senior Director of Drug Information, and Kyle Hoelting, Senior Manager of Drug Information at Vizient, share their insights on the history and current state of evidence-based medicine within the practitioner community. They also discuss how to reverse the trend of using anecdotal experience and swing the pendulum back to increased reliance on evidenced based medicine.

Guest speakers:

Kyle Hoelting, PharmD, BCPS

Moderator:

Show Notes:

[00:55-2:18] Kyle and Stacy’s backgrounds

[02:19-3:45] Evidence Based Medicine definition and history

[03:46-5:54] Current state of EBM

[05:55-10:45] Basic tools of EBM

[10:46-14:29] Difference between clinical and statistical significance

[14:30-15:56] Outcomes  

[15:57-18:28] Role of FDA in promoting EBM

[18:29-20:27] How pharmacy and therapeutics committees incorporate EBM

[20:28-21:15] EBM Resources

Links | Resources:

Seigfried RJ, Corbo T, Saltzberg MT, Reitz J, Bennett DA. Deciding which drugs get onto the formulary: a value-based approach Value Health. 2013 Jul-Aug;16(5):901-6.

Riegelman RK, Nelson BA. Studying a Study & Testing a Test: Reading Evidence-Based Health Research. Philadelphia: Wolters Kluwer; 2021.

Gehlbach SH. Interpreting the Medical Literature. 5th ed. New York: McGraw Hill; 2006.

Malone PM, Malone MJ, Park SK. Drug information: a guide for pharmacists. 6th ed. New York:  McGraw Hill; 2014.

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed